SpyGlass Pharma is a United States-based ophthalmology company developing drug delivery technologies and therapeutic products for eye diseases. Its work focuses on sustained-delivery approaches intended for ophthalmic treatment.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!